Related Experiment Videos
Effect of cyclophosphamide on experimental acute hematogenous pyelonephritis caused by Staphylococcus saprophyticus
The Indian Journal of Medical Research
|March 1, 1987
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Characterization of novel polysulfide polymer coated fly ash and its application in mitigating diffusion of contaminants.
Environmental pollution (Barking, Essex : 1987)·2024
Polysaccharide and monosaccharide guided liver delivery of Sorafenib Tosylate - A nano-strategic approach and comparative assessment of hepatospecificity.
International journal of pharmaceutics·2022
Erratum: Resistance & virulence traits in dermatophytes isolated from Mangaluru, India.
The Indian journal of medical research·2026
Erratum: Workplace exposure to aflatoxins & its health effects: A systematic review.
The Indian journal of medical research·2026
Microtubule disruption and apoptotic induction by Vibrio cholerae haemagglutinin protease: Implications for anticancer therapy in colon and gastric tumours.
The Indian journal of medical research·2026
Association of childhood growth with adult lung function: A prospective urban birth cohort study from India.
The Indian journal of medical research·2026
Persistent high diphtheria positivity in North India: Evidence from a tertiary hospital-based study, 2007-2021.
The Indian journal of medical research·2026
A mobile based antimicrobial susceptibility testing device - prototype development and validation.
The Indian journal of medical research·2026
Delayed kidney response in AL amyloidosis: prevalence and clinical significance.
Clinical kidney journal·2026
Role of fibroblast growth factor-23 in renal disease activity and bone density involvement in patients with lupus nephritis.
World journal of nephrology·2026
Transurethral versus Suprapubic Catheterization in Acute Bacterial Prostatitis: Clinical Predictors and Outcomes.
Urologia internationalis·2026
Evaluating sparsentan for the treatment of focal segmental glomerulosclerosis.
Expert opinion on pharmacotherapy·2026